Patent Assignment
Reel/Frame 022059/0280
Assignment of Assignor's Interest
Recorded: 2009-01-05
Pages: 6
Assignor
UMANA, PABLO
Executed: 2008-10-21
Assignee
GLYCART BIOTECHNOLOGY AG
WAGISTRASSE 18, A SWISS COMPANY, CH-8952 SCHLIEREN, SWITZERLAND
Covered Property
(1)
Combination Therapy of Type Ii Anti-CD20 Antibody with a Proteasome Inhibitor
Application:
12/234,759 →
Publication:
US 2009/0110688
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2008
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE, INC.
Reel/Frame 021997/0979 →
Assignment of Assignor's Interest
Mar 6, 2009
From: FERTIG, GEORG; FRIESS, THOMAS; KLEIN, CHRISTIAN
To: F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY
Reel/Frame 022362/0532 →
Assignment of Assignor's Interest
May 27, 2010
From: HOFFMANN-LA ROCHE INC.
To: ROCHE GLYCART AG
Reel/Frame 024464/0418 →
Change of Name
Jun 29, 2010
From: GLYCART BIOTECHNOLOGY AG
To: ROCHE GLYCART AG
Reel/Frame 024624/0566 →